Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity?

被引：4
|
作者：
Guglielmetti, Lorenzo [1 ,2 ,3 ]
机构：
[1] Med Sans Frontieres, Paris, France
[2] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France
[3] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CIMI,CR7,Team E13 Bacteriol,U1135, Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 49卷 / 05期
关键词：
MYCOBACTERIUM-TUBERCULOSIS; ACQUIRED-RESISTANCE; DELAMANID; TB; COHORT; FLUOROQUINOLONES; COMPASSIONATE; MANAGEMENT; TMC207; DRUGS;
D O I：
10.1183/13993003.00738-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging
    Li, Yang
    Sun, Feng
    Zhang, Wenhong
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (01) : 98 - 105
  • [2] Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis
    Olaru, Ioana D.
    Heyckendorf, Jan
    Andres, Soenke
    Kalsdorf, Barbara
    Lange, Christoph
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [3] Evaluating bedaquiline as a treatment option for multidrug-resistant tuberculosis
    Martin-Garcia, Marta
    Esteban, Jaime
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (05) : 535 - 541
  • [4] Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
    Guglielmetti, Lorenzo
    Le Du, Damien
    Veziris, Nicolas
    Caumes, Eric
    Marigot-Outtandy, Dhiba
    Yazdanpanah, Yazdan
    Robert, Jerome
    Frechet-Jachym, Mathilde
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 582 - 585
  • [5] Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
    Pontali, Emanuele
    Sotgiu, Giovanni
    D'Ambrosio, Lia
    Centis, Rosella
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 394 - 402
  • [6] Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
    Cox, V
    Brigden, G.
    Crespo, R. H.
    Lessem, E.
    Lynch, S.
    Rich, M. L.
    Waning, B.
    Furin, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (04) : 407 - +
  • [7] Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
    Worley, Marylee V.
    Estrada, Sandy J.
    PHARMACOTHERAPY, 2014, 34 (11): : 1187 - 1197
  • [8] Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
    Guglielmetti, Lorenzo
    Jaspard, Marie
    Le Du, Damien
    Lachatre, Marie
    Marigot-Outtandy, Dhiba
    Bernard, Christine
    Veziris, Nicolas
    Robert, Jerome
    Yazdanpanah, Yazdan
    Caumes, Eric
    Frechet-Jachym, Mathilde
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [9] Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?
    Field, Stephen K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (04) : 170 - 184
  • [10] Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Tuberculosis
    Chahine, Elias B.
    Karaoui, Lamis R.
    Mansour, Hanine
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (01) : 107 - 115
12345